Comprehensive molecular characterization of human colon and rectal cancer.

Cancer genome landscapes. Science (2013) 25.33

Signatures of mutational processes in human cancer. Nature (2013) 21.63

Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature (2013) 20.16

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal (2013) 19.54

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13

Mutational landscape and significance across 12 major cancer types. Nature (2013) 14.91

Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08

Comprehensive molecular characterization of gastric adenocarcinoma. Nature (2014) 11.93

The somatic genomic landscape of glioblastoma. Cell (2013) 11.73

The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet (2013) 11.29

Pan-cancer patterns of somatic copy number alteration. Nat Genet (2013) 7.73

WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64

Emerging landscape of oncogenic signatures across human cancers. Nat Genet (2013) 6.48

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet (2012) 6.25

A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med (2013) 6.09

The causes and consequences of genetic heterogeneity in cancer evolution. Nature (2013) 5.91

Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet (2013) 4.61

Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48

The consensus molecular subtypes of colorectal cancer. Nat Med (2015) 4.35

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med (2013) 4.22

Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell (2014) 4.17

Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls. Nat Biotechnol (2014) 4.07

A Big Bang model of human colorectal tumor growth. Nat Genet (2015) 3.77

Revisiting global gene expression analysis. Cell (2012) 3.63

Proteogenomic characterization of human colon and rectal cancer. Nature (2014) 3.61

Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol (2013) 3.57

Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer. Cell (2015) 3.54

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet (2013) 3.51

β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell (2012) 3.33

Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21

Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci U S A (2013) 3.15

Network-based stratification of tumor mutations. Nat Methods (2013) 3.12

Replication stress links structural and numerical cancer chromosomal instability. Nature (2013) 3.11

Interplay between the cancer genome and epigenome. Cell (2013) 3.05

Medulloblastomics: the end of the beginning. Nat Rev Cancer (2012) 3.01

Integrative annotation of variants from 1092 humans: application to cancer genomics. Science (2013) 2.98

Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency. Gastroenterology (2014) 2.96

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med (2013) 2.96

Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun (2013) 2.94

Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst (2015) 2.94

TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res (2012) 2.90

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer. Cancer Discov (2013) 2.87

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature (2014) 2.81

Integrated genomic characterization of oesophageal carcinoma. Nature (2017) 2.76

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma. Cell (2016) 2.65

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res (2013) 2.57

Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nat Rev Cancer (2014) 2.54

CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood (2012) 2.51

Emerging patterns of somatic mutations in cancer. Nat Rev Genet (2013) 2.50

Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov (2013) 2.49

The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes. Nat Commun (2014) 2.48

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci U S A (2014) 2.46

Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science (2014) 2.42

Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer (2013) 2.41

ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell (2013) 2.32

Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci Transl Med (2013) 2.30

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res (2013) 2.27

A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat Commun (2014) 2.25

Comprehensive genomic profiles of small cell lung cancer. Nature (2015) 2.20

Visualizing multidimensional cancer genomics data. Genome Med (2013) 2.19

Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A (2014) 2.12

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med (2016) 2.04

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. Genome Res (2014) 2.03

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Proc Natl Acad Sci U S A (2013) 2.02

Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis (2013) 2.02

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest (2014) 2.01

A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis. Genet Med (2014) 2.00

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer. J Clin Oncol (2015) 2.00

Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival. World J Surg (2014) 1.98

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol (2013) 1.95

Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Gastroenterology (2014) 1.93

Putative cis-regulatory drivers in colorectal cancer. Nature (2014) 1.92

DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. Hum Mol Genet (2013) 1.87

The mutational landscape of adenoid cystic carcinoma. Nat Genet (2013) 1.83

Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res (2012) 1.82

MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal Chem (2014) 1.81

Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing. Cancer (2014) 1.80

Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas. Nat Genet (2013) 1.80

Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol (2014) 1.76

Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science (2014) 1.74

Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol (2014) 1.71

Simultaneous identification of multiple driver pathways in cancer. PLoS Comput Biol (2013) 1.71

Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J Pathol (2013) 1.71

ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells. J Exp Med (2013) 1.70

The future of epigenetic therapy in solid tumours--lessons from the past. Nat Rev Clin Oncol (2013) 1.70

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04. J Clin Oncol (2014) 1.70

Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers. Genome Med (2013) 1.68

The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell (2013) 1.68

Hypermutation in human cancer genomes: footprints and mechanisms. Nat Rev Cancer (2014) 1.67

IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature (2014) 1.66

SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair. Oncogene (2015) 1.65

Assessment of computational methods for predicting the effects of missense mutations in human cancers. BMC Genomics (2013) 1.64

Simultaneous identification and prioritization of variants in familial, de novo, and somatic genetic disorders with VariantMaster. Genome Res (2014) 1.63

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat Genet (2014) 1.63

Epiviz: interactive visual analytics for functional genomics data. Nat Methods (2014) 1.63

Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev (2013) 1.62

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. Cancer Cell (2015) 1.61

Large scale comparison of gene expression levels by microarrays and RNAseq using TCGA data. PLoS One (2013) 1.61

Pattern discovery and cancer gene identification in integrated cancer genomic data. Proc Natl Acad Sci U S A (2013) 1.60

Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40

The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02

Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72

The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A (2007) 18.83

BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods (2009) 18.41

The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet (2008) 16.09

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97

Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52

Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (1993) 12.74

TGFbeta signaling in growth control, cancer, and heritable disorders. Cell (2000) 12.38

Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol (2009) 9.43

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics (2010) 8.44

Molecular genetics of colorectal cancer. Annu Rev Pathol (2011) 7.24

Mutual exclusivity analysis identifies oncogenic network modules. Genome Res (2011) 7.22

Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell (2009) 7.08

SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer (2011) 6.87

Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science (2003) 6.85

Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell (1993) 6.61

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet (2011) 5.67

Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science (2007) 5.08

Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res (2011) 4.84

Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell (2011) 4.74

Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol (2007) 4.52

SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology (2007) 4.17

An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science (2007) 4.00

Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet (1986) 3.93

Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat (2011) 3.63

Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain. Gut (2010) 3.24

Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. Proc Natl Acad Sci U S A (2011) 2.72

Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene (1987) 2.67

Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem (2008) 2.57

Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci U S A (2000) 2.38

The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest. Cancer Res (2006) 2.36

Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res (2010) 2.30

Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev (2011) 2.29

A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription. Cancer Res (2010) 2.05

Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res (2010) 2.01

Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes Chromosomes Cancer (2009) 1.91

Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol Cancer Res (2005) 1.87

S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells. Mol Biol Cell (2011) 1.71

Unique considerations in the patient with rectal cancer. Semin Oncol (2011) 1.49

Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers. BMC Cancer (2010) 1.48

Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39

Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature (2015) 5.50

Genomic Classification of Cutaneous Melanoma. Cell (2015) 3.91

Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A (2014) 1.37

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep (2017) 0.76

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep (2017) 0.75